A decrease in the levels of PEDF that are found in circulation has the potential to improve insulin sensitivity, which would position PEDF as a possible novel therapeutic target for diabetes mellitus and other metabolic disorders, respectively [281]. The gene discussed is INS; the disease is metabolic disease.